Search results for multiple sclerosis.
Found 12 clinical studies.
Brain Shuttle (Bp42230) A Study To Test The Safety And Effect Of The Study Drug At Different Dose Levels, Determine How Well It Is Tolerated, And Measure How The Body Absorbs And Distributes The Study Drug
- Investigator: Lawrence Goldstick
- Posted Date: Dec 14, 2022
- Type of Study: Drug
Phase 1/2, Two-Part, Open-Label Dose-Escalation And Double-Blind, Placebo-Controlled Dose-Expansion Study With An Open-Label Extension To Evaluate The Safety And Efficacy Of Ata188 In Subjects With Progressive Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Jun 22, 2021
- Type of Study: Drug
An Open-Label, Multicenter Phase 4 Study To Assess Disease Activity And Biomarkers Of Neuronal Damage In Minority Patients With Relapsing Multiple Sclerosis Receiving Treatment With Ocrelizumab
- Investigator: Lawrence Goldstick
- Posted Date: Mar 19, 2021
- Type of Study: Drug
Bn42083 A Phase IIIb Multicenter, Randomized, Double-Blind, Controlled Study To Evaluate The Efficacy, Safety And Pharmacokinetics Of A Higher Dose Of Ocrelizumab In Adults With Primary Progressive Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Feb 15, 2021
- Type of Study: Drug
A Phase 3, Randomized, Double-Blind, Efficacy And Safety Study Comparing Sar442168 To Placebo In Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis (Hercules)
- Investigator: Lawrence Goldstick
- Posted Date: Oct 27, 2020
- Type of Study: Drug
Gn42272: A Phase III Randomized, Double-Blind Study To Evaluate Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Patients With Relapsing Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Oct 23, 2020
- Type of Study: Drug
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progressive Multiple Sclerosis
- Investigator: Aram Zabeti
- Posted Date: Aug 25, 2020
- Type of Study: Drug
Long-Term Extension Safety And Efficacy Study Of Sar442168 In Participants With Relapsing Multiple Sclerosis
- Investigator: Lawrence Goldstick
- Posted Date: Oct 10, 2019
- Type of Study: Drug
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis (Ocarina)
- Investigator: Lawrence Goldstick
- Posted Date: Oct 7, 2019
- Type of Study: Drug
Traditional Versus Early Aggressive Therapy For Multiple Sclerosis (Treat-Ms) Trial
- Investigator: Aram Zabeti
- Posted Date: May 15, 2019
- Type of Study: Drug
A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1A
- Investigator: Aram Zabeti
- Posted Date: May 15, 2019
- Type of Study: Drug
Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Participants With Early Stage Relapsing Remitting Multiple Sclerosis (Rrms)
- Investigator: Aram Zabeti
- Posted Date: May 15, 2019
- Type of Study: Drug